Detalhe da pesquisa
1.
Immune profiles of pre-frail people living with HIV-1: a prospective longitudinal study.
Immun Ageing
; 21(1): 20, 2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38481213
2.
Long-Acting Cabotegravir and Rilpivirine Dosed Every 2 Months in Adults With Human Immunodeficiency Virus 1 Type 1 Infection: 152-Week Results From ATLAS-2M, a Randomized, Open-Label, Phase 3b, Noninferiority Study.
Clin Infect Dis
; 76(9): 1646-1654, 2023 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36660819
3.
Does exposure to different menstrual products affect the vaginal environment?
Mol Ecol
; 32(10): 2592-2601, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36057782
4.
CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses.
Nature
; 543(7646): 564-567, 2017 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28297712
5.
Corrigendum: CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses.
Nature
; 546(7660): 686, 2017 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28658234
6.
Angiotensin II induces reactive oxygen species, DNA damage, and T-cell apoptosis in severe COVID-19.
J Allergy Clin Immunol
; 150(3): 594-603.e2, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35841981
7.
Effect of Antibiotic Exposure on Staphylococcus epidermidis Responsible for Catheter-Related Bacteremia.
Int J Mol Sci
; 24(2)2023 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36675063
8.
Once-daily dolutegravir versus darunavir plus cobicistat in adults at the time of primary HIV-1 infection: the OPTIPRIM2-ANRS 169 randomized, open-label, Phase 3 trial.
J Antimicrob Chemother
; 77(9): 2506-2515, 2022 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35762503
9.
Dolutegravir-based dual maintenance regimens combined with lamivudine/emtricitabine or rilpivirine: risk of virological failure in a real-life setting.
J Antimicrob Chemother
; 77(1): 196-204, 2021 12 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34651192
10.
Deep sequencing analysis of M184V/I mutation at the switch and at the time of virological failure of boosted protease inhibitor plus lamivudine or boosted protease inhibitor maintenance strategy (substudy of the ANRS-MOBIDIP trial).
J Antimicrob Chemother
; 76(5): 1286-1293, 2021 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33624081
11.
Spices to Control COVID-19 Symptoms: Yes, but Not Only .
Int Arch Allergy Immunol
; 182(6): 489-495, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33352565
12.
Potential Interplay between Nrf2, TRPA1, and TRPV1 in Nutrients for the Control of COVID-19.
Int Arch Allergy Immunol
; 182(4): 324-338, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33567446
13.
Pre-exposure prophylaxis makes it possible to better live one's sexuality and guide men who have sex with men towards a responsible approach to their health: a phenomenological qualitative study about primary motivations for PrEP.
AIDS Res Ther
; 18(1): 2, 2021 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33413434
14.
Increased Prevalence of Neurocognitive Impairment in Aging People Living With Human Immunodeficiency Virus: The ANRS EP58 HAND 55-70 Study.
Clin Infect Dis
; 70(12): 2641-2648, 2020 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31755936
15.
Multimorbidity in Elderly Persons According to the Year of Diagnosis of Human Immunodeficiency Virus Infection: A Cross-sectional Dat'AIDS Cohort Study.
Clin Infect Dis
; 71(11): 2880-2888, 2020 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31813982
16.
Rilpivirine in HIV-1-positive women initiating pregnancy: to switch or not to switch?
J Antimicrob Chemother
; 75(5): 1324-1331, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32157283
17.
Characterization of viral rebounds on dual etravirine/raltegravir maintenance therapy (ANRS-163 ETRAL trial).
J Antimicrob Chemother
; 75(7): 1943-1949, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32259255
18.
Abnormal liver tests in patients hospitalized with Coronavirus disease 2019: Should we worry?
Liver Int
; 40(8): 1860-1864, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32495496
19.
Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort.
J Antimicrob Chemother
; 74(3): 754-760, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30534993
20.
Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study.
J Antimicrob Chemother
; 74(9): 2742-2751, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31269208